Literature DB >> 12431207

Interobserver variation in interpretation of serial liver biopsies from patients with chronic hepatitis C.

K Grønbaek1, P B Christensen, S Hamilton-Dutoit, B H Federspiel, E Hage, O J Jensen, M Vyberg.   

Abstract

Reliable and accurate assessment of liver histopathology in patients with chronic hepatitis C is important for decision regarding treatment and for evaluation of therapy. However, little data on interobserver variation have been published. In this study, five specialist histopathologists evaluated 46 liver biopsies from 20 patients treated with interferon-alpha. Knodell's and Ishak's scoring systems, De Groote's classification and a four level general necro-inflammatory activity score (GNAS) were applied. Besides kappa statistics, slide by slide analysis was performed. We defined an acceptable slide by slide agreement as eight of ten observer pairs agreed on 80% of the slides. The best agreement was seen for Knodell's and Ishak's fibrosis score, De Groote's classification and GNAS (mean weighted kappa (kappa(w)) = 0.49, 0.51, 0.50 and 0.44, respectively). By condensing data from Knodell's and Ishak's scores to presence or absence of cirrhosis and piecemeal necrosis respectively, concordance was substantial concerning cirrhosis (mean kappa = 0.69 and 0.72, respectively) but only moderate concerning piecemeal necrosis (mean kappa = 0.40 and 0.39, respectively). Slide by slide analysis showed the highest agreement on Knodell's fibrosis score and GNAS; only one point of difference in score was to be accepted to obtain 'eight of ten' agreement. In contrast, five points of difference were necessary to accept in order to reach the same agreement for Knodell's total activity score. Moreover, in serial biopsies the GNAS was sufficient to detect changes in disease activity following treatment. Thus, a simple scoring system with four category scales was reproducible and sufficient for detection of therapy induced changes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12431207     DOI: 10.1046/j.1365-2893.2002.00389.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  20 in total

1.  Apoptosis in chronic viral hepatitis parallels histological activity: an immunohistochemical investigation using anti-activated caspase-3 and M30 cytodeath antibody.

Authors:  Jo L McPartland; Muna Ali Guzail; Charles H Kendall; James Howard Pringle
Journal:  Int J Exp Pathol       Date:  2005-02       Impact factor: 1.925

2.  Clinical Utility of Biomarkers of Liver Fibrosis.

Authors:  Keyur Patel; Don C Rockey
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-01

3.  Design and validation of the biliary atresia research consortium histologic assessment system for cholestasis in infancy.

Authors:  Pierre Russo; John C Magee; John Boitnott; Kevin E Bove; Trivellore Raghunathan; Milton Finegold; Joel Haas; Ronald Jaffe; Grace E Kim; Margret Magid; Hector Melin-Aldana; Frances White; Peter F Whitington; Ronald J Sokol
Journal:  Clin Gastroenterol Hepatol       Date:  2011-01-14       Impact factor: 11.382

4.  Refinement and reproducibility of histologic criteria for the assessment of microscopic lesions in patients with gastroesophageal reflux disease: the Esohisto Project.

Authors:  Lisa Yerian; Roberto Fiocca; Luca Mastracci; Robert Riddell; Michael Vieth; Prateek Sharma; Stefan Franzen; Paula Fernstrom; Magnus Ruth
Journal:  Dig Dis Sci       Date:  2011-03-02       Impact factor: 3.199

5.  Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience.

Authors:  Jignesh Patel; Eric E Sigmund; Henry Rusinek; Marcel Oei; James S Babb; Bachir Taouli
Journal:  J Magn Reson Imaging       Date:  2010-03       Impact factor: 4.813

6.  Inter-observer variability in histopathological assessment of liver biopsies taken in a pediatric open label therapeutic program for chronic HBV infection treatment.

Authors:  Marek Woynarowski; Joanna Cielecka-Kuszyk; Andrzej Kałuzyński; Aleksandra Omulecka; Maria Sobaniec-Łotowska; Julian Stolarczyk; Wojciech Szczepański
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

7.  Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study.

Authors:  E S Andersen; S Rødgaard-Hansen; B Moessner; P B Christensen; H J Møller; Nina Weis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-10       Impact factor: 3.267

8.  A comparison of hepatopathologists' and community pathologists' review of liver biopsy specimens from patients with hepatitis C.

Authors:  Maire Robert; Andre N Sofair; Ann Thomas; Beth Bell; Stephanie Bialek; Christopher Corless; Grace Van Ness; Sharon Huie-White; Nicole Stabach; Atif Zaman
Journal:  Clin Gastroenterol Hepatol       Date:  2008-12-13       Impact factor: 11.382

9.  Label-free classification of hepatocellular-carcinoma grading using second harmonic generation microscopy.

Authors:  Hongxin Lin; Liyan Lin; Guangxing Wang; Ning Zuo; Zhenlin Zhan; Shusen Xie; Gang Chen; Jianxin Chen; Shuangmu Zhuo
Journal:  Biomed Opt Express       Date:  2018-07-24       Impact factor: 3.732

10.  Interobserver Variability in Histologic Evaluation of Liver Fibrosis Using Categorical and Quantitative Scores.

Authors:  Michael Pavlides; Jacqueline Birks; Eve Fryer; David Delaney; Nikita Sarania; Rajarshi Banerjee; Stefan Neubauer; Eleanor Barnes; Kenneth A Fleming; Lai Mun Wang
Journal:  Am J Clin Pathol       Date:  2017-04-01       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.